Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

INTRODUCTION: Clinical trials of new treatments for rheumatoid arthritis (RA) typically require subjects to have an elevated acute phase reactant (APR), in addition to tender and swollen joints. However, despite the elevation of individual components of the Clinical Disease Activity Index (CDAI) (te...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kay, Jonathan, Morgacheva, Olga, Messing, Susan P, Kremer, Joel M, Greenberg, Jeffrey D, Reed, George W, Gravallese, Ellen M, Furst, Daniel E
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978994/
https://ncbi.nlm.nih.gov/pubmed/24485007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4469
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados